Category: Business

  • Investors Panic as Nigerian Exchange Traders Drive NGX Market Into a Selective Freefall in Lagos Amid Rising Institutional Sell-Off Signals on June 4 Session

    Investors Panic as Nigerian Exchange Traders Drive NGX Market Into a Selective Freefall in Lagos Amid Rising Institutional Sell-Off Signals on June 4 Session

    The Nigerian equities market closed lower for a second straight session on Thursday, June 4, with selling pressure pushing the benchmark All-Share Index down by 0.37% to 242,227.31 points.

    Despite the decline, trading activity remained relatively robust.

    Investors exchanged 588.46 million shares valued at ₦27.88 billion across 57,352 transactions, while total market capitalization settled at ₦155.36 trillion.

    Although the headline loss appeared modest, market data suggested a deeper shift in investor behavior, with capital increasingly flowing toward a limited number of high-quality stocks rather than the broader market.

    Institutional Funds Continue to Dominate Key Counters

    One of the session’s clearest themes was the concentration of large-value trades in a handful of major stocks.

    The highest transaction values were recorded in NGX Group, Zenith Bank and Access Holdings, which attracted ₦3.89 billion, ₦3.32 billion and ₦2.62 billion respectively.

    The pattern indicates that institutional investors remain active and committed to liquid, fundamentally strong companies

    However, analysts noted that while large investors are still deploying capital, participation is becoming more selective than during the earlier stages of the market rally.

    Such concentration often reflects a more cautious approach, where professional investors maintain exposure to equities while limiting risk by focusing on market leaders.

    Trading Participation Weakens Across the Market

    A comparison with trading figures from June 2 highlights a noticeable slowdown in overall market participation.

    Total volume declined from 718.77 million shares to 588.46 million shares, representing a reduction of roughly 130 million units.

    At the same time, the number of deals fell sharply from 71,683 to 57,352.

    While both volume and transaction count weakened, turnover value remained relatively strong at nearly ₦28 billion.

    This divergence suggests that larger investors continue to execute sizeable transactions even as participation from smaller market players declines.

    Such conditions typically point to increasing institutional influence and a reduction in retail-driven activity.

    Smart Money Focuses on Banks While Retail Traders Chase Momentum

    Market activity revealed a growing divide between institutional and retail investment strategies.

    Large investors continued to channel funds into banking stocks and other liquid counters, particularly NGX Group and leading financial institutions.

    Meanwhile, retail traders appeared more focused on speculative opportunities in lower-priced stocks and momentum-driven plays.

    Among the session’s notable gainers were OMATEK, which advanced 9.73%, INTENEGINS with a 10% rise, and CUTIX, which gained 9.66%.

    The contrast between institutional positioning and speculative buying suggests that while confidence remains in select blue-chip names, risk appetite among retail investors is increasingly concentrated in short-term opportunities.

    Aradel’s Sharp Decline Raises Questions

    One of the most closely watched developments of the day was the steep decline in Aradel Holdings, which lost 9.51%.

    The stock has been among the market’s preferred institutional plays in recent months, making its sharp pullback particularly significant.

    Large-cap stocks often exert considerable influence on overall market direction, and weakness in such counters can provide an early indication of changing sentiment among major investors.

    Although a single trading session does not establish a trend, market participants are likely to monitor Aradel closely in the coming days for signs of continued selling pressure.

    Winners and Losers Define a Mixed Trading Session

    The day’s strongest performers included FGSUK2033S6, which climbed 12.34%, alongside INTENEGINS, OMATEK, ABBEYBDS and CUTIX.

    On the downside, MCNICHOLS led the losers’ chart with a 10% decline, followed by ABCTRANS, ETERNA, ARADEL and FGSUK2027S3.

    The distribution of gainers and losers highlighted a market where advances were largely concentrated in smaller stocks rather than the dominant large-cap names that typically drive sustained rallies.

    Signs of a More Mature Market Rally

    Current market conditions suggest that the bullish trend remains intact, supported by healthy liquidity levels and continued institutional interest in banking stocks and other major counters.

    However, several indicators point to a more advanced phase of the rally.

    Participation is narrowing, trading volume has softened, and some market leaders are beginning to face profit-taking pressure.

    At the same time, speculative activity is becoming increasingly prominent.

    These developments are commonly associated with a market transitioning from broad-based momentum to a more selective environment where stock-picking becomes increasingly important.

    Risks Rising but No Signs of Panic Yet

    Market conditions do not currently indicate widespread fear or panic selling.

    Nevertheless, risk levels appear to be gradually increasing.

    Liquidity growth has slowed, fewer stocks are driving overall performance, and profit-taking activity is becoming more frequent.

    The recent weakness in some heavyweight counters further reinforces the need for caution.

    The next few trading sessions are expected to provide important clues about the market’s direction.

    Continued institutional support for banking stocks could help sustain the broader uptrend, while further declines in volume and weakness among leading stocks may increase the likelihood of a deeper pullback.

    Investors Shift From Broad Exposure to Selective Positioning

    Thursday’s trading session revealed more than the modest 0.37% decline reflected in the benchmark index.

    Underneath the surface, market participation continued to soften as volumes and transaction counts retreated.

    Yet strong turnover in NGX Group, Zenith Bank and Access Holdings demonstrated that institutional investors remain firmly engaged.

    Rather than exiting the market, major investors appear to be reallocating capital toward high-quality, liquid stocks while becoming increasingly selective elsewhere.

    The result is a market that still retains a constructive outlook but demands greater discipline from investors.

    As leadership narrows and liquidity moderates, the ability to identify fundamentally strong stocks may become more important than simply maintaining broad market exposure.

    Banking stocks and other institutional favorites are likely to remain key indicators of the market’s next significant move.

  • CerraCap Impact Venture Capital Installs Ex-PayPal and Bank of America Tech Chief Mark Rohrwasser as CXO Council Leader in Costa Mesa, California, Triggering Talk of Venture Capital Power Consolidation

    CerraCap Impact Venture Capital Installs Ex-PayPal and Bank of America Tech Chief Mark Rohrwasser as CXO Council Leader in Costa Mesa, California, Triggering Talk of Venture Capital Power Consolidation

    CerraCap Impact Venture Capital has announced the appointment of seasoned technology leader Mark Rohrwasser to spearhead its CXO Council, a strategic advisory group designed to deepen executive-level insight across its investment portfolio in frontier technologies.

    The move reflects the firm’s continued push into high-growth sectors such as artificial intelligence, cybersecurity, healthcare innovation, advanced computing, defense technologies, aerospace systems, and enterprise software.

    Decades of Leadership Experience Across Global Tech and Finance Giants

    Rohrwasser brings more than 35 years of experience spanning financial services, cybersecurity transformation, enterprise infrastructure, and large-scale digital modernization programs.

    His leadership background includes senior roles at major global organizations including Silicon Valley Bank, Equifax, PayPal, Bank of America, and General Electric.

    Across these roles, he has overseen complex technology upgrades, strengthened cybersecurity frameworks, and led enterprise-wide transformation initiatives aimed at improving operational resilience and digital competitiveness.

    His experience is expected to play a central role in guiding venture-backed companies navigating rapid technological disruption.

    CXO Council Set to Strengthen Investment Strategy and Portfolio Growth

    The CXO Council is positioned as a high-level advisory platform bringing together experienced chief executives, chief technology officers, and senior enterprise leaders.

    Its core purpose is to support investment decision-making by offering real-world operational insight and market intelligence drawn from decades of industry leadership.

    For CerraCap Impact Venture Capital, the council will contribute directly to the execution of its Fund III and Fund IV strategies, particularly during due diligence processes.

    Members will help identify emerging enterprise technology trends, evolving cybersecurity demands, and shifting corporate spending priorities across global industries.

    Bridging Investors, Founders, and Enterprise Expertise

    Beyond investment analysis, the council is intended to function as a bridge between founders, portfolio companies, and seasoned operators.

    Its members will work closely with startups to evaluate enterprise readiness, refine product strategies, and strengthen go-to-market execution.

    By connecting early-stage innovators with experienced executives, the initiative aims to reduce execution risk while accelerating commercialization timelines and improving product-market alignment.

    A Curated Network Focused on Innovation and Enterprise Value Creation

    Structured as an exclusive community of senior technology leaders, the CXO Council is also designed to foster collaboration, knowledge sharing, and exposure to emerging technologies.

    Members will gain access to cutting-edge innovation while providing portfolio companies with direct access to enterprise decision-makers.

    Ultimately, the initiative is expected to reinforce CerraCap Impact Venture Capital’s positioning as a key player in enterprise innovation and value creation, leveraging deep operational expertise to support the next generation of technology companies.

  • Backswing Ventures Surpasses 1.0x DPI in Windermere, Florida as Fund II Delivers Early Cash Returns to LPs Through Two Rapid Exits Raising Questions in Defense VC Circles

    Backswing Ventures Surpasses 1.0x DPI in Windermere, Florida as Fund II Delivers Early Cash Returns to LPs Through Two Rapid Exits Raising Questions in Defense VC Circles

    Backswing Ventures, a Windermere, Florida-based venture capital firm investing in dual-use and defense technologies, has announced that its Fund II—launched in 2023—has exceeded a major performance milestone by surpassing 1.0x Distributed to Paid-In Capital (DPI).

    The achievement means the fund has returned more capital to investors than was originally contributed, accomplished in just over three years since inception.

    Early Exits Drive Full Capital Return to Investors

    The milestone was reached through only two completed exits within the portfolio, both of which generated sufficient liquidity to fully repay limited partners and push total distributions beyond the fund’s committed capital.

    This relatively limited number of exits underscores the strength of the realizations achieved so far, with early liquidity events driving a performance outcome that many venture funds typically take significantly longer to reach.

    Portfolio Still Positioned for Further Upside

    Despite the realized returns, Fund II remains actively invested, with eight portfolio companies still in place.

    Alongside surpassing the 1.0x DPI mark, the fund continues to show a strong Multiple on Invested Capital (MOIC), indicating that both realized gains and unrealized positions are contributing to overall performance.

    The remaining companies continue to operate across sectors expected to generate long-term value, suggesting that additional upside may still materialize as the portfolio matures.

    Focus on Defense, Aerospace, and Security Technologies

    Backswing Ventures concentrates its investments in companies developing advanced capabilities across aerospace, autonomous systems, defense platforms, cybersecurity, infrastructure, and broader national security technologies.

    This thematic focus reflects growing investor interest in dual-use innovation, where commercial and defense applications intersect, particularly in areas tied to technological sovereignty and critical infrastructure resilience.

    Liquidity Strategy and Active Portfolio Management

    Under the leadership of Managing Partner Kyle Asman, the firm has adopted an approach that prioritizes earlier liquidity events while maintaining disciplined investment selection.

    The strategy is designed to return capital to limited partners as efficiently as possible, allowing them to redeploy funds into new opportunities.

    Rather than holding investments indefinitely, Backswing evaluates exit opportunities on an ongoing basis, considering partial or full sales when it believes most of the risk-adjusted upside has been captured or when another buyer may be better positioned to accelerate the company’s next phase of growth.

    Balancing Early Returns with Long-Term Growth Potential

    The firm’s approach blends active portfolio management with opportunistic secondary market participation, aiming to reduce downside exposure while still capturing meaningful upside from high-growth defense and technology companies.

    With Fund II already surpassing full capital return while several investments remain active, the performance highlights a model that seeks to balance early distributions with continued participation in long-term value creation.

  • Tramlines Ventures Expands Bold AI Startup Strategy in London, UK as Venture Firm Closes First Fund Round While Scaling 24-Month Accelerator Program for Founders

    Tramlines Ventures Expands Bold AI Startup Strategy in London, UK as Venture Firm Closes First Fund Round While Scaling 24-Month Accelerator Program for Founders

    Tramlines Ventures, a London-based early-stage investor focused on AI-native services companies led by domain-expert founders, has reached the first close of its inaugural Fund I.

    The vehicle is aiming for a final close of £10 million as it builds momentum in its push to back a new wave of artificial intelligence-driven startups across the UK and beyond.

    The milestone marks a key step in the firm’s broader strategy of combining capital deployment with structured company-building support for early-stage founders.

    Early Investors Include Family Offices and Experienced Founders

    The first close attracted a mix of family offices, exited entrepreneurs, and seasoned private market investors.

    This blend of backers reflects growing appetite for hands-on venture models that go beyond traditional capital injection and instead provide operational and strategic support to startups.

    According to the firm, these investors were drawn to its integrated approach, which combines funding with an accelerator-style growth programme designed to actively shape portfolio companies from the earliest stages.

    £10m Fund to Back 30 AI-Native Startups at Pre-Seed Stage

    Fund I is designed to deploy capital into 30 early-stage companies over the next three years, with initial investments of around £250,000 at pre-seed level.

    The fund will focus specifically on AI-native services businesses led by founders with deep industry expertise.

    Each company is expected to enter a structured 24-month accelerator programme intended to help them scale rapidly while embedding artificial intelligence into core operations from day one.

    The firm’s ambition is to build companies that are not only AI-enabled but fundamentally designed around AI-driven systems and workflows.

    Accelerator Model Blends Capital, Infrastructure and AI Transformation

    Tramlines’ approach combines investment with a hands-on operating model that includes commercial infrastructure and an AI transformation programme.

    The initiative is supported by leadership with experience in large-scale technology transformation, including a former National Technology Officer at Microsoft.

    The 24-month accelerator is designed to guide startups through product development, market entry, and scaling, while integrating AI systems to improve efficiency and competitiveness from an early stage.

    Strong Second Raise for Management Company Signals Investor Confidence

    Alongside the fund’s first close, the firm’s management company has also completed its second funding round since launching one year ago.

    It secured more than £2 million in a seed round at a £22.5 million pre-money valuation, following a previous £1 million raise at an £8 million valuation in April 2025.

    This rapid valuation growth highlights increasing investor confidence in the firm’s model and execution strategy as it scales its operations.

    Leadership Team Brings Cross-Sector Experience in Media, Finance and Technology

    The venture firm is led by Founder and CEO Albert Azis-Clauson and chaired by Craig Donaldson, who also serves as a commercial lead within the portfolio.

    Key leadership roles include Glen Robinson, and Andrew Winters, who leads the accelerator programme after senior roles in consulting and technology operations.

    Fund I itself is led by Daniel Lanyon, bringing experience across fintech, venture capital, and asset management.

    Supporting the leadership team are Erica Young, Ashleigh Gardner, and Andrea Madaschi, who contributes extensive financial and investment analysis expertise.

    Together, the team is positioning the firm as both a capital provider and an operating partner for the next generation of AI-driven startups.

  • Amazon Slashes Price on Shark NV602UKT Vacuum Cleaner in UK as Shoppers Rush to Grab 40% Discount Deal Amid Pet Hair Cleaning Debate

    Amazon Slashes Price on Shark NV602UKT Vacuum Cleaner in UK as Shoppers Rush to Grab 40% Discount Deal Amid Pet Hair Cleaning Debate

    A well-known cordless-style upright cleaner aimed at pet owners has been heavily discounted on Amazon, with the Shark NV602UKT Lift-Away model now reduced by around 40%, making it one of the more notable home appliance deals currently circulating online.

    The price cut has drawn attention from shoppers looking for mid-range vacuum cleaners that combine strong suction power with pet-focused features at a lower entry cost.

    High Customer Ratings Highlight Strong Consumer Demand

    The Shark NV602UKT has built a strong reputation on Amazon, backed by more than 13,000 customer reviews and an average rating of around 4.6 stars.

    According to marketplace data, the model has also seen a surge in recent purchases, with thousands of units reportedly sold within a short period, suggesting continued demand despite its age in the market.

    Built for Pet Owners Facing Everyday Cleaning Challenges

    Marketed primarily toward households with pets, the vacuum is designed to handle persistent issues such as embedded fur, dust buildup, and allergens commonly found in carpets and upholstery.

    Manufactured by Shark, the cleaner aims to address the everyday difficulties of maintaining floors in homes with cats or dogs, particularly where shedding is frequent and difficult to manage with standard vacuum models.

    Lift-Away Design and Anti-Allergen System Among Key Features

    One of the main selling points of the NV602UKT is its Lift-Away technology, which allows the main canister to be detached from the upright frame.

    This makes it easier for users to clean stairs, furniture, and tight corners without carrying the full weight of the machine.

    The vacuum also includes dedicated pet hair tools, crevice attachments, and upholstery brushes to improve reach and versatility across different surfaces.

    Shark’s Anti-Allergen Complete Seal system is designed to trap up to 99.9% of dust and allergens inside the unit, preventing particles from being released back into the air during cleaning.

    Additional features include LED headlights for spotting hidden dirt, an 8-metre power cable, and a dust capacity of approximately 1.1 litres.

    Discount Brings Price Down to £139 With Warranty Included

    The current promotion has reduced the price of the Shark NV602UKT to approximately £139, representing a saving of nearly £91 compared to its original recommended retail price.

    Customers purchasing through Amazon also benefit from a five-year manufacturer guarantee when the product is registered after purchase, adding long-term value to the discounted offer.

    Why the Deal Is Gaining Attention Among Shoppers

    The combination of strong user ratings, pet-focused engineering, and a significant price reduction has helped push the vacuum into Amazon’s list of trending home appliance deals.

    For many buyers, the appeal lies in securing a well-reviewed cleaning device at a lower price point, particularly at a time when pet ownership and home maintenance spending continue to rise across UK households.

  • Controversial Venture Debt Surge Uncovered by Runway Growth Capital Study as American Startups Rake in Record $68.8B in Loans While Exit Values Skyrocket Across U.S. Markets

    Controversial Venture Debt Surge Uncovered by Runway Growth Capital Study as American Startups Rake in Record $68.8B in Loans While Exit Values Skyrocket Across U.S. Markets

    A newly released industry study from Runway Growth Capital has highlighted a significant shift in private financing, showing that venture debt has climbed to unprecedented levels even as deal activity holds steady.

    Produced in collaboration with PitchBook, the 2025–2026 Venture Debt Review takes a close look at how companies are increasingly turning to debt financing as an alternative to equity fundraising in a market still dominated by concentrated investment trends, particularly in artificial intelligence.

    The report paints a picture of a maturing funding environment where capital efficiency, ownership preservation, and structured borrowing are becoming central to growth strategies.

    Venture Debt Climbs to $68.8 Billion Despite Stable Deal Volume

    One of the standout findings shows U.S. venture debt reaching a record $68.8 billion in 2025.

    While total capital deployed surged, the number of transactions remained largely unchanged at around 1,000 deals.

    This divergence suggests a shift toward larger, more structured financing rounds rather than a broad expansion in deal-making activity.

    Companies are not necessarily borrowing more frequently, but they are borrowing more when they do, signaling increased confidence from lenders in borrower quality and financial visibility.

    Larger Deal Sizes and Rising Follow-On Activity Signal Market Deepening

    The report highlights a clear upward movement in deal sizing across the market.

    The 75th percentile deal size rose to $27.7 million, while the median climbed to $5.5 million, reflecting stronger capital needs and more sophisticated borrowing structures.

    Follow-on financing activity also expanded significantly, increasing from $4.7 billion across 129 deals in 2024 to $12.3 billion across 156 deals in 2025.

    This growth underscores a pattern where companies are returning to debt markets multiple times as part of their funding lifecycle rather than relying on one-time financing events.

    These trends point to a more embedded role for venture debt in long-term capital planning rather than short-term liquidity support.

    Debt Becomes a Strategic Tool for Growth-Focused Companies

    According to the report, venture debt is increasingly being adopted by later-stage companies with stable revenue profiles, strong customer retention, and predictable cash flows.

    Instead of serving as a last-resort financing option, it is now being integrated into deliberate capital strategies.

    Borrowers with stronger fundamentals are finding easier access to structured debt as lenders prioritize revenue visibility and durable business models.

    In sectors such as healthtech and cleantech, financing structures are also evolving to reflect asset-backed or contracted revenue streams, further expanding eligibility beyond traditional software businesses.

    David Spreng noted that this shift reflects a broader move toward financing discipline, where companies balance growth ambitions with ownership preservation.

    AI Dominance Persists While New Sectors Gain Ground

    Even as the market broadens, artificial intelligence and SaaS continue to anchor the majority of activity.

    SaaS alone accounted for more than $28 billion in financing for the second consecutive year, reinforcing its position as a core pillar of venture-backed lending.

    However, the report also points to rising activity in healthtech, cleantech, and intellectual property-heavy businesses.

    These sectors are increasingly structured to support debt financing due to recurring revenue models, contracted cash flows, or asset-backed value creation.

    This expansion signals that venture debt is no longer confined to traditional software models but is adapting to a wider range of industries with predictable financial structures.

    Exit Activity Strengthens as Venture Debt Backed Firms Gain Share

    Exit markets also showed notable strength in 2025, reaching $286.9 billion in total value.

    Companies supported by venture debt accounted for 37% of overall exit value and 18% of total exit transactions, both representing an increase compared to the previous year.

    The findings suggest that debt-backed companies are playing a growing role in liquidity events, particularly as investors seek more efficient capital structures ahead of exits.

    Looking toward 2026, the report expects venture debt to expand further as equity markets remain concentrated and selective.

    In this environment, structured debt financing is positioned as both a stabilizing force and a competitive advantage for companies seeking flexible growth capital.

    The full report is available here: Venture Debt Review Report

  • MSWA and Founders Factory Launch Neurological Care Accelerator in Perth as Five Startups Spark Debate Over AI Brain Tech Replacing Traditional Stroke Prevention Methods

    MSWA and Founders Factory Launch Neurological Care Accelerator in Perth as Five Startups Spark Debate Over AI Brain Tech Replacing Traditional Stroke Prevention Methods

    A new wave of innovation in neurological healthcare is taking shape as Australian not-for-profit MSWA, in partnership with global accelerator and venture studio Founders Factory, unveils the first cohort of startups joining its MS & Neurological Care Accelerator.

    The initiative is designed to speed up the development of technologies that can improve daily life for people living with complex neurological conditions, including multiple sclerosis (MS), stroke, Parkinson’s disease, Huntington’s disease, motor neurone disease (MND), and acquired brain injury.

    Real-World Testing Through Clinical Collaboration

    Unlike traditional startup programs, the accelerator offers participating ventures direct access to MSWA’s extensive clinical network and a community of thousands of individuals affected by neurological conditions across Western Australia, South Australia, and the Northern Territory.

    This access will allow startups to test and refine their innovations in real-world environments, helping ensure that solutions are not only technologically advanced but also practical and responsive to patient needs.

    A Mix of Emerging Technologies Driving New Care Models

    The selected startups are working across a wide range of cutting-edge technologies, including artificial intelligence, brain-computer interfaces, robotics, wearable devices, and advanced health monitoring tools.

    These innovations are aimed at addressing both physical and cognitive challenges faced by patients, with a focus on improving independence, mobility, communication, and overall quality of life.

    Meet the Five Startups in the First Cohort

    The inaugural group features five early-stage companies from different parts of the world, each developing distinct approaches to neurological care.

    London-based upLYFT is building a “Movement Intelligence” platform that turns everyday textiles into an invisible system for tracking health and performance, offering new ways to understand movement patterns.

    From San Francisco, Neurosonic is developing a stroke prevention solution that detects and monitors carotid artery blockages using blood flow sound analysis supported by a proprietary database.

    Melbourne’s Fluent is working on a subscalp brain-computer interface designed to decode speech, potentially offering new communication pathways for individuals affected by severe neurological impairments.

    Clarity Technologies, based between San Francisco and Paris, is creating a device that uses sensory stimulation therapy to address neurodegenerative symptoms, including fatigue experienced by people living with MS.

    Boston-based ReVimo is developing a portable robotic self-transfer device that helps individuals with mobility challenges move out of bed and perform daily self-care tasks more safely and independently.

    Global Accelerator to Operate from Western Australia

    The MS & Neurological Care Tech Accelerator will be based in Perth, Western Australia, positioning the region as a growing hub for neurotechnology innovation and healthcare advancement.

    Through this initiative, MSWA continues its broader mission of supporting individuals living with neurological conditions and providing essential services to affected communities across multiple Australian regions.

    By combining clinical expertise with startup innovation, the program aims to accelerate the delivery of practical, life-changing technologies for people living with neurological disorders worldwide.

  • 645 Ventures Promotes William Hess to Principal in a Controversial Talent Advancement Decision Across New York City and San Francisco That Signals a Major Shift in Early-Stage Investment Direction

    645 Ventures Promotes William Hess to Principal in a Controversial Talent Advancement Decision Across New York City and San Francisco That Signals a Major Shift in Early-Stage Investment Direction

    Early-stage venture capital firm 645 Ventures has announced the promotion of William Hess to Principal, marking a significant step forward in his career within the New York and San Francisco-based investment firm.

    The move underscores the firm’s continued focus on strengthening its investment leadership team as it expands its portfolio across multiple high-growth sectors.

    Expanding Responsibility Across Key Investment Sectors

    In his elevated role, Hess will continue to be deeply involved with the firm’s Investment and Research division, where he works closely with both emerging founders and established portfolio companies.

    His coverage spans several dynamic industries, including fintech, hard tech, consumer technology, and iGaming—sectors that remain central to 645 Ventures’ investment strategy.

    Over the course of his tenure, Hess has contributed to investments across a wide range of companies, including Shield AI, True Anomaly, Sequence, Edge, Clerq, Meridian, Forterra, Firestorm, and Jackpot.

    His work has included supporting founders through early growth stages and helping position companies for scale.

    From Operator to Investor: Hess’s Career Path

    Before joining 645 Ventures, Hess built experience on both sides of the startup ecosystem, working as an operator and later transitioning into investment roles.

    His prior experience includes roles at FanDuel, where he gained exposure to high-growth consumer and sports technology markets, and at Thrive Capital, a prominent venture capital firm known for backing category-defining technology companies.

    This combination of operating and investing experience has shaped his approach at 645 Ventures, particularly in evaluating early-stage companies and working closely with founders navigating scaling challenges.

    Strengthening a Data-Driven Venture Platform

    645 Ventures, led by Managing Partners Aaron Holiday and Nnamdi Okike, continues to position itself as a technology-enabled investment firm.

    Central to its strategy is the Voyager software platform, which supports its internal Success team and broader Connected Network designed to help portfolio companies accelerate growth.

    The firm’s portfolio includes several companies that have successfully moved into the growth stage, such as Iterable, Goldbelly, Resident, Eden Health, FiscalNote, and Squire, reflecting its focus on supporting founders beyond early capital into scaling and expansion phases.

  • EU Banking Authority and New York Financial Regulator Forge Controversial Stablecoin Surveillance Pact in Brussels and New York to Track Crypto Flows Across Borders and Tighten Market Control Amid Rising $319 Billion Industry

    EU Banking Authority and New York Financial Regulator Forge Controversial Stablecoin Surveillance Pact in Brussels and New York to Track Crypto Flows Across Borders and Tighten Market Control Amid Rising $319 Billion Industry

    European and U.S. financial watchdogs have moved to tighten coordination over the fast-growing stablecoin sector, signing a new cooperation agreement aimed at improving supervision of cross-border digital asset activity.

    The European Banking Authority (EBA) and the New York State Department of Financial Services (NYDFS) formalized a memorandum of understanding designed to align regulatory approaches and improve information sharing between Europe and New York.

    A Framework Built Around MiCA and Cross-Border Coordination

    According to the EBA, the agreement falls under its responsibilities within the European Union’s Markets in Crypto-Assets (MiCA) framework, which began shaping the region’s crypto oversight architecture after its rollout.

    The arrangement establishes structured procedures for exchanging supervisory data and tracking market developments.

    It also sets out how both regulators will coordinate assessments of risks linked to stablecoin issuance and usage across their respective jurisdictions.

    Shared Data, Market Signals, and Risk Monitoring

    Under the agreement, the two authorities will exchange a wide range of supervisory information.

    This includes details on stablecoin issuance volumes, total supply in circulation, holder distribution, audit results, and the regulatory status of firms operating in the sector.

    Officials say the goal is to improve visibility into market dynamics that often stretch across borders, especially as stablecoins are used increasingly in payments and trading infrastructure.

    NYDFS Emphasizes Market Integrity and Supervision

    The NYDFS said the partnership is intended to strengthen oversight of companies involved in stablecoin activity, while also helping regulators detect emerging risks and broader market trends.

    The agency also highlighted its aim of reinforcing confidence in the sector by ensuring that regulated entities operate under consistent supervisory expectations, particularly as stablecoins become more integrated into traditional financial systems.

    Stablecoins Gain Ground in Global Payments Experimentation

    Stablecoins have seen growing adoption among banks and financial institutions in both the United States and Europe, particularly for testing faster and cheaper cross-border payments.

    This experimentation has accelerated alongside clearer regulatory frameworks in both regions.

    The global stablecoin market has expanded significantly, reaching more than $319 billion in total value, according to data from DeFiLlama.

    Regulation Expands in the U.S. and EU as Market Matures

    The agreement comes amid a broader wave of regulatory developments on both sides of the Atlantic.

    The European Union’s MiCA rules came into effect toward the end of 2024, establishing a unified approach to crypto asset supervision across member states.

    In the United States, stablecoin legislation was signed into law in July by President Donald Trump, adding federal structure to a market previously governed largely at the state level.

    Despite this regulatory momentum, some industry voices argue the sector may be entering a slower growth phase.

    Axis co-founder Jimmy Xue has previously suggested that stablecoin expansion is leveling off after years of rapid growth, pointing to tighter liquidity conditions, evolving regulation, and stronger returns in traditional markets as factors shaping demand.

  • Meiji Seika Pharma Expands Global Influence as It Funnels Strategic Investment Into GHIC Health Security Fund Operating From New York in Bold Pandemic Defense Strategy

    Meiji Seika Pharma Expands Global Influence as It Funnels Strategic Investment Into GHIC Health Security Fund Operating From New York in Bold Pandemic Defense Strategy

    Tokyo-based pharmaceutical firm Meiji Seika Pharma Co., Ltd. has announced a strategic investment in the Global Health Security Fund (GHSF), a venture capital initiative focused on strengthening global preparedness against infectious disease threats and other public health emergencies.

    The fund is sponsored by the Global Health Investment Corporation (GHIC), a nonprofit organization headquartered in New York.

    The move signals Meiji Seika Pharma’s intent to deepen its involvement in innovation-driven health security solutions, particularly in areas where rapid scientific development is critical to saving lives.

    Focus on Pandemic Preparedness and Antimicrobial Resistance

    The investment is expected to help accelerate the development of new technologies targeting some of the most urgent global health risks, including pandemic preparedness and antimicrobial resistance (AMR).

    These areas have become central concerns for health systems worldwide following recent outbreaks and the growing challenge of drug-resistant infections.

    By participating in the fund, Meiji Seika Pharma joins a growing coalition of investors and health stakeholders committed to supporting early-stage and scalable solutions designed to improve global response capacity during health crises.

    GHIC’s Mission-Driven Investment Model

    The Global Health Investment Corporation, which manages the GHSF initiative, operates under a model that blends public health objectives with private-sector investment strategies.

    Led by Chairman and CEO Labeeb Abboud, the organization aims to generate both measurable health outcomes and sustainable financial returns.

    GHIC works in close partnership with the U.S. Biomedical Advanced Research and Development Authority (BARDA), using venture capital mechanisms to speed up the development and deployment of medical technologies that address urgent health security threats.

    Through this collaboration, GHSF was established as a dedicated investment platform to back companies working on innovative solutions in global health preparedness.

    Strong Track Record of Global Impact

    GHIC reports that its portfolio companies have already brought more than a dozen health products to market.

    These innovations have collectively reached over 600 million people worldwide, underscoring the scale of impact the organization aims to achieve through its investment strategy.

    The fund’s approach focuses not only on innovation but also on ensuring that successful medical technologies can be scaled and distributed globally, particularly in regions most vulnerable to outbreaks and health system strain.

    Meiji Seika Pharma’s Longstanding Role in Healthcare

    Meiji Seika Pharma brings a long history in pharmaceutical development to its participation in the fund.

    Since introducing penicillin in 1946, the company has expanded its portfolio across multiple therapeutic areas, including treatments for infectious diseases, central nervous system disorders, hematologic conditions, and generic medicines.

    The company’s investment in GHSF aligns with its broader commitment to advancing healthcare solutions that address both established and emerging medical challenges, reinforcing its role in the global pharmaceutical landscape.